By controlling cancer stem cells (CSCs) or influencing the genes required to activate downstream pathways such as ErbB-PI3K-AKT (Protein Kinase B) or WNT-signaling cascades, CDK12 facilitates cancer progression [188]. This evidence concerns the gene EGFR and cancer.